Osteoarthritis Trial, Recruiting (NCT06298721)

Osteoarthritis Trial, Recruiting NCT06298721 Sponsor: The Cleveland Clinic Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT06298721 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 19 and 79 years of age
People who are proficient in English
People who are willing to sign a consent form agreeing to take part in the study
People who are scheduled to have a single knee replacement on one knee only (not both at the same time)
People whose responses to knee health questionnaires suggest a higher risk of being unsatisfied with their knee replacement outcome (confirm with trial site)
People who are able and willing to attend all required follow-up appointments as outlined in the study plan

Who may not be able to join:

People who need both knees replaced, either at the same time or in two separate surgeries scheduled less than 90 days apart
People who are having a repeat or corrective knee replacement surgery (revision surgery)
People who have an inflammatory form of arthritis, such as rheumatoid arthritis
People who have had a previous infection in the knee being considered for replacement
People who belong to a protected population, such as those who are incarcerated or who have been assessed as not having the mental capacity to consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nicolas S Piuzzi, MD, Cleveland Clinic Ohio

Phone: 4199658274

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06298721

Sponsor: The Cleveland Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: 4199658274

More information: https://clinicaltrials.gov/study/NCT06298721

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 19 and 79 years of age
People who are proficient in English
People who are willing to sign a consent form agreeing to take part in the study
People who are scheduled to have a single knee replacement on one knee only (not both at the same time)
People whose responses to knee health questionnaires suggest a higher risk of being unsatisfied with their knee replacement outcome (confirm with trial site)
People who are able and willing to attend all required follow-up appointments as outlined in the study plan

Who may not be able to join:

People who need both knees replaced, either at the same time or in two separate surgeries scheduled less than 90 days apart
People who are having a repeat or corrective knee replacement surgery (revision surgery)
People who have an inflammatory form of arthritis, such as rheumatoid arthritis
People who have had a previous infection in the knee being considered for replacement
People who belong to a protected population, such as those who are incarcerated or who have been assessed as not having the mental capacity to consent

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Cleveland Clinic

Registry

ClinicalTrials.gov

Start date

12 March 2024

Est. completion

1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Satisfaction at 1 year

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov